ASO Author Reflections: Evolving Paradigms in the Management of Peritoneal Metastases Recurrences: Repeat Cytoreductive Surgery with HIPEC or Not-Insights from French Expert Centers
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sugarbaker P
. It Is What the Surgeon Does Not See That Kills the Patient. J Clin Med. 2024; 13(8).
PMC: 11051342.
DOI: 10.3390/jcm13082238.
View
2.
Abdel Mageed H, van Der Speeten K, Sugarbaker P
. The many faces of intraperitoneal chemotherapy. Surg Oncol. 2021; 40:101676.
DOI: 10.1016/j.suronc.2021.101676.
View
3.
van de Vlasakker V, Lurvink R, Cashin P, Ceelen W, Deraco M, Goere D
. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2021; 47(11):2888-2892.
DOI: 10.1016/j.ejso.2021.05.023.
View
4.
Tidadini F, Arvieux C, Glehen O, Sourrouille I, Marchal F, Abba J
. ASO Visual Abstract: Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French.... Ann Surg Oncol. 2024; 32(4):2947-2948.
DOI: 10.1245/s10434-024-16706-7.
View
5.
Sadeghi B, Arvieux C, Glehen O, Beaujard A, Rivoire M, Baulieux J
. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000; 88(2):358-63.
DOI: 10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o.
View